Who owns Crispr Therapeutics Ag?
- Ticker: CRSP
- CUSIP Number: h17182108
Tip: Access positions for across all investors
Analyze quarterly positions in Crispr Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Top investors of Crispr Therapeutics stock
Who bought or sold Crispr Therapeutics Ag this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
ARK Investment Management | 8.2M | $556M | -4% | Mar 2024 |
|
Capital Research and Management Company - Division 3 | 7.8M | $534M | 28% | Mar 2024 |
|
Nikko Asset Management Americas | 3.3M | $223M | -3% | Mar 2024 |
|
Sumitomo Mitsui Trust Holdings | 3.2M | $170M | -4% | Jun 2024 |
|
T. Rowe Price Investment Management | 2.7M | $184M | 100% | Mar 2024 |
|
BlackRock | 2.5M | $174M | 100% | Mar 2024 |
|
FMR | 2.2M | $153M | 100% | Mar 2024 |
|
Vanguard Group | 1.6M | $112M | 3% | Mar 2024 |
|
NEA Management Company | 1.6M | $180M | 0% | Mar 2024 |
|
Citadel Advisors | 1.6M | $106M | -27% | Mar 2024 |
|
State Street Corporation | 1.5M | $102M | -15% | Mar 2024 |
|
EcoR1 Capital | 1.4M | $95M | 100% | Mar 2024 |
|
Susquehanna International | 1.4M | $93M | 100% | Mar 2024 |
|
Morgan Stanley | 1.1M | $131M | 100% | Mar 2024 |
|
Sr One Capital Management | 1.0M | $72M | 100% | Mar 2024 |
|
Bank of America Corporation | 1.0M | $71M | 20% | Mar 2024 |
|
Loomis, Sayles and | 1.0M | $70M | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 931k | $64M | 19% | Mar 2024 |
|
Geode Capital Management | 909k | $62M | 100% | Mar 2024 |
|
Credit Suisse | 719k | $49M | -18% | Mar 2024 |
|
Caption Management | 680k | $46M | -31% | Mar 2024 |
|
Charles Schwab Investment Management | 669k | $46M | 2% | Mar 2024 |
|
Contrarius Investment Management | 666k | $45M | 264% | Mar 2024 |
|
Bellevue Group | 620k | $42M | -31% | Mar 2024 |
|
T. Rowe Price Associates | 600k | $41M | -31% | Mar 2024 |
|
Versant Venture Management | 499k | $34M | 0% | Mar 2024 |
|
Federated Investors | 448k | $31M | -12% | Mar 2024 |
|
venBio Select Advisor | 420k | $29M | 100% | Mar 2024 |
|
D. E. Shaw & Co | 406k | $28M | 43% | Mar 2024 |
|
Baillie Gifford & Co | 405k | $22M | 2% | Jun 2024 |
|
Jpmorgan Chase & Co | 393k | $27M | -15% | Mar 2024 |
|
Capital Fund Management | 363k | $25M | 100% | Mar 2024 |
|
UBS Group | 360k | $25M | -7% | Mar 2024 |
|
Squarepoint Ops | 345k | $24M | 93% | Mar 2024 |
|
Barclays | 324k | $22M | -37% | Mar 2024 |
|
Pictet Asset Management Holding SA | 321k | $22M | 100% | Mar 2024 |
|
PEAK6 Investments | 311k | $21M | 915% | Mar 2024 |
|
Capital Advisors | 264k | $18M | 3% | Mar 2024 |
|
Vestmark Advisory Solutions | 250k | $17M | 44% | Mar 2024 |
|
Northern Trust | 243k | $17M | 100% | Mar 2024 |
|
Integral Health Asset Management | 220k | $15M | 100% | Mar 2024 |
|
Wells Fargo & Company | 216k | $15M | 29% | Mar 2024 |
|
Eagle Health Investments | 197k | $13M | 100% | Mar 2024 |
|
Armistice Capital | 192k | $13M | 100% | Mar 2024 |
|
Jane Street | 175k | $12M | -63% | Mar 2024 |
|
TD Asset Management | 167k | $11M | -26% | Mar 2024 |
|
Mirae Asset Global Investments | 167k | $11M | 86% | Mar 2024 |
|
Spear Holdings RSC | 165k | $8.9M | 0% | Jun 2024 |
|
Woodline Partners | 164k | $11M | 100% | Mar 2024 |
|
Wolverine Trading | 159k | $11M | -15% | Mar 2024 |
|
Ameriprise Financial | 157k | $11M | 100% | Mar 2024 |
|
Gts Securities | 151k | $10M | -35% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 149k | $10M | 252% | Mar 2024 |
|
Swiss National Bank | 149k | $10M | 0% | Mar 2024 |
|
Nordea Investment Management Ab | 149k | $10M | 41% | Mar 2024 |
|
William Blair $ Company | 148k | $10M | 8% | Mar 2024 |
|
Capital International Sarl | 142k | $9.7M | 38% | Mar 2024 |
|
Goldman Sachs Group | 140k | $9.6M | -35% | Mar 2024 |
|
Capital International | 127k | $8.6M | 34% | Mar 2024 |
|
Rafferty Asset Management | 124k | $8.4M | 100% | Mar 2024 |
|
Cutter Capital Management | 120k | $8.2M | 12% | Mar 2024 |
|
Tang Capital Management | 117k | $7.9M | -46% | Mar 2024 |
|
Ubs Global Asset Management Americas | 111k | $7.5M | 15% | Mar 2024 |
|
Man Group | 110k | $7.5M | -53% | Mar 2024 |
|
Millennium Management | 109k | $7.4M | 530% | Mar 2024 |
|
CalPERS | 108k | $7.3M | 0% | Mar 2024 |
|
LPL Financial | 106k | $7.2M | 100% | Mar 2024 |
|
Carnegie Capital Asset Management | 102k | $5.5M | 51% | Jun 2024 |
|
Frontier Capital Management | 102k | $7.0M | 100% | Mar 2024 |
|
Citigroup | 102k | $6.9M | -9% | Mar 2024 |
|
Baker Chad R | 99k | $5.3M | 0% | Jun 2024 |
|
Reynders McVeigh Capital Management | 97k | $6.6M | 5% | Mar 2024 |
|
Walleye Trading | 96k | $6.6M | -57% | Mar 2024 |
|
Capital International | 92k | $6.2M | 34% | Mar 2024 |
|
Advisor Group Holdings | 91k | $6.2M | 1% | Mar 2024 |
|
Lazard Asset Management | 86k | $5.9M | -11% | Mar 2024 |
|
Royal Bank of Canada | 85k | $5.7M | -6% | Mar 2024 |
|
Legal & General Group | 83k | $5.7M | 24% | Mar 2024 |
|
Slow Capital | 79k | $4.3M | 17% | Jun 2024 |
|
Rockefeller Capital Management | 79k | $5.4M | -1% | Mar 2024 |
|
Allspring Global Investments Holdings | 79k | $5.4M | 113% | Mar 2024 |
|
Bank of New York Mellon | 79k | $4.3M | 4% | Jun 2024 |
|
Van Eck Associates Corp. | 72k | $4.9M | 6% | Mar 2024 |
|
Hrt Financial | 69k | $4.7M | 100% | Mar 2024 |
|
Himension Fund | 69k | $4.7M | 100% | Mar 2024 |
|
California State Teachers Retirement System | 68k | $4.6M | 100% | Mar 2024 |
|
Affinity Asset Advisors | 65k | $4.4M | 100% | Mar 2024 |
|
Congress Asset Management | 65k | $4.4M | 60% | Mar 2024 |
|
Virtu Financial | 64k | $4.3M | 107% | Mar 2024 |
|
Walleye Trading Advisors | 63k | $4.3M | 16% | Mar 2024 |
|
Stifel Financial | 59k | $4.1M | 8% | Mar 2024 |
|
McGuire Investment Group | 58k | $3.1M | 0% | Jun 2024 |
|
Raymond James Financial Services Advisors | 57k | $3.1M | 25% | Jun 2024 |
|
Cambridge Investment Research Advisors | 56k | $3.8M | 18% | Mar 2024 |
|
Readystate Asset Management | 56k | $3.8M | 100% | Mar 2024 |
|
State of Wisconsin Investment Board | 55k | $3.7M | -11% | Mar 2024 |
|
Commonwealth Equity Services | 54k | $3.7M | 16% | Mar 2024 |
|
Shellback Capital | 51k | $3.5M | 100% | Mar 2024 |
|
Guggenheim Capital, LLC Managers | 50k | $3.4M | 39% | Mar 2024 |
|
Trexquant Investment | 50k | $3.4M | -62% | Mar 2024 |
|
Two Sigma Investments | 49k | $3.3M | -42% | Mar 2024 |
|
Atika Capital Management | 48k | $3.3M | 100% | Mar 2024 |
|
Torno Capital | 45k | $3.1M | 337% | Mar 2024 |
|
State of New Jersey Common Pension Fund D | 45k | $3.1M | -8% | Mar 2024 |
|
Voloridge Investment Management | 44k | $3.0M | -94% | Mar 2024 |
|
Two Sigma Securities | 43k | $2.9M | -52% | Mar 2024 |
|
HighTower Advisors | 43k | $2.9M | 13% | Mar 2024 |
|
Tudor Investment Corporation | 42k | $2.9M | -22% | Mar 2024 |
|
Envestnet Asset Management | 41k | $2.8M | 100% | Mar 2024 |
|
Granite Bay Wealth Management | 41k | $2.4M | 100% | Jun 2024 |
|
Bayesian Capital Management | 41k | $2.8M | 100% | Mar 2024 |
|
DekaBank Deutsche Girozentrale | 41k | $2.8M | 2% | Mar 2024 |
|
Principal Financial Group | 41k | $2.8M | 100% | Mar 2024 |
|
Mitsubishi UFJ Trust & Banking Corp | 40k | $2.7M | -6% | Mar 2024 |
|
Raymond James & Associates | 38k | $2.1M | 10% | Jun 2024 |
|
Susquehanna Portfolio Strategies | 37k | $2.5M | 100% | Mar 2024 |
|
B & T Capital Management DBA Alpha Capital Management | 37k | $2.0M | -17% | Jun 2024 |
|
UBS O'Connor | 36k | $24k | 100% | Mar 2024 |
|
Diam | 36k | $1.9M | 33% | Jun 2024 |
|
West Family Investments | 36k | $2.4M | 0% | Mar 2024 |
|
Hennion & Walsh Asset Management | 35k | $1.9M | 107% | Jun 2024 |
|
Henderson Group | 35k | $2.4M | 0% | Mar 2024 |
|
RMB Capital Management | 34k | $2.3M | 9% | Mar 2024 |
|
Cetera Investment Advisers | 34k | $2.3M | 100% | Mar 2024 |
|
Wealth Enhancement Advisory Services | 32k | $1.7M | 134% | Jun 2024 |
|
Invesco | 32k | $2.2M | -38% | Mar 2024 |
|
Thrivent Financial for Lutherans | 31k | $2.1M | 100% | Mar 2024 |
|
Capital Investment Advisory Services | 30k | $2.1M | -5% | Mar 2024 |
|
Oppenheimer & Co | 30k | $2.0M | 100% | Mar 2024 |
|
Baird Financial | 30k | $2.0M | 100% | Mar 2024 |
|
Nuveen Asset Management | 30k | $2.0M | 100% | Mar 2024 |
|
Ensign Peak Advisors | 29k | $1.9M | 100% | Mar 2024 |
|
Macquarie Group | 28k | $1.9M | 100% | Mar 2024 |
|
Patriot Financial Group Insurance Agency | 27k | $1.9M | -6% | Mar 2024 |
|
Green Alpha Advisors | 27k | $1.8M | 10% | Mar 2024 |
|
Capital Group Investment Management Pte | 27k | $1.8M | 32% | Mar 2024 |
|
Ing Investment Management | 26k | $1.8M | 100% | Mar 2024 |
|
SG Americas Securities | 26k | $1.4M | -33% | Jun 2024 |
|
Captrust Financial Advisors | 25k | $1.7M | -5% | Mar 2024 |
|
Entropy Technologies | 25k | $1.7M | 100% | Mar 2024 |
|
Ipswich Investment Management | 24k | $1.3M | -2% | Jun 2024 |
|
Bedell Investment Counselling | 24k | $1.6M | 100% | Mar 2024 |
|
Group One Trading | 24k | $1.6M | 100% | Mar 2024 |
|
Susquehanna Fundamental Investments | 24k | $1.6M | 100% | Mar 2024 |
|
TrueNorth | 23k | $1.3M | -2% | Jun 2024 |
|
Schroder Investment Management Group | 23k | $1.6M | 0% | Mar 2024 |
|
CWM | 22k | $1.2M | 11871% | Jun 2024 |
|
Bouvel Investment Partners | 22k | $1.2M | 0% | Jun 2024 |
|
Hedges Asset Management | 22k | $1.2M | 13% | Jun 2024 |
|
Verition Fund Management | 21k | $1.5M | 100% | Mar 2024 |
|
Aquatic Capital Management | 21k | $1.4M | -45% | Mar 2024 |
|
Manufacturers Life Insurance Company | 20k | $1.4M | -31% | Mar 2024 |
|
Yiheng Capital | 6.3k | $429k | -98% | Mar 2024 |
|
Who sold out of Crispr Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Ikarian Capital | Dec 2023 | 724k | $45M |
Norges Bank Investment Management | Dec 2023 | 618k | $39M |
LMR Partners | Dec 2023 | 60k | $3.8M |
Jump Financial | Dec 2023 | 42k | $2.7M |
Twin Tree Management | Dec 2023 | 40k | $2.5M |
Cubist Systematic Strategies | Dec 2023 | 38k | $2.4M |
IMC-Chicago | Mar 2024 | 37k | $2.5M |
Leucadia National Corporation | Dec 2023 | 25k | $1.6M |